Breast Cancer Trial, Recruiting NCT07190066 Sponsor: Harokopio University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07190066
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who currently live in Greece, Lithuania, Spain, or Sweden
  • Women aged 18 years or older
  • People who are able to understand and complete study questionnaires in the local language of one of the participating countries
  • People who are able to give their full informed consent to take part
  • People who have access to and are able to use a smartphone that runs iOS or Android and can support the study app
  • People who fall into one of the following groups: women with a Body Mass Index (BMI) of 25 or higher, or who do not meet the World Health Organization's recommendation of at least 150 minutes of moderate-to-vigorous physical activity per week; women currently receiving treatment for breast cancer or waiting to start breast cancer treatment; or women who have had breast cancer and finished active treatment at least six months before joining the study

Who may not be able to join:

  • People who are unable to give their full informed consent to take part
  • People who are unable to understand or communicate in the local language of one of the participating countries

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yannis Manios, Professor, Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece

Phone: +30 2109549156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Harokopio University
Registry
ClinicalTrials.gov
Start date
22 April 2025
Est. completion
30 September 2025

Where this trial is recruiting

🇬🇷 Greece 🇱🇹 Lithuania 🇪🇸 Spain 🇸🇪 Sweden

Primary endpoints

Usability; Relevance, appropriateness and usefulness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov